Home › NDC Lookup › Ingredients › Succinylcholine Chloride › 70771-1352-07
💉image loading
(from DailyMed)

Succinylcholine Chloride 20 mg/mL Injection, Solution — NDC 70771-1352-7 (Billing 70771-1352-07)

by Zydus Lifesciences Limited · 25 VIAL, MULTI-DOSE in 1 TRAY / 10 mL in 1 VIAL, MULTI-DOSE

This is a package of Succinylcholine Chloride 20 mg/mL Injection, Solution from Zydus Lifesciences Limited, marketed since May 2018 and currently FDA-listed. It is this product's only package size.

NDC 70771-1352-07
🏷️ FDA NDC (as labeled) 70771-1352-7 billing pads the package segment with a zero
Rx only Generic On market Non-controlled ⇄ Compare with another NDC
🗂️ FDA directory synced Oct 1, 2026 · this listing last changed Jul 24, 2026 · sources: openFDA · FDA label (DailyMed) · FDA Orange & Purple Book · First Databank · CMS NADAC, ASP, Medicare & Medicaid · RxNorm
📋 All sources & update times →
⚠️
Other active recalls for Succinylcholine Chloride (different manufacturers) — 1 · tap to view
These affect other manufacturers’ products for the same ingredient — not necessarily the exact NDC on this page.
Class II · Aug 27, 2025 — Failed Impurities/Degradation Specifications: Out-of-Specification test results obtained for any individual unknown degradation impurity. (Zydus Pharmaceuticals (USA) Inc) · FDA recall D-0623-2025
Each entry is an official FDA enforcement report — look up any recall number in the FDA recall database ↗

Identity & classification

Regulatory identifiers FDA, NLM and CMS codes for this package

FDA NDC (as labeled) 70771-1352-7
Product NDC 70771-1352
11-digit billing NDC 70771135207
RxCUI 1594589
UNII I9L0DDD30I
Application # ANDA209467
SPL Set ID c7f409ed-e4f4-4cd6-8f37-93f505dd986d
Established class (EPC) Depolarizing Neuromuscular Blocker
Physiologic effect Neuromuscular Depolarizing Blockade
DEA schedule Non-controlled
Marketing category ANDA
Marketing status On market
FDA listing status Listed (active directory)
Marketing start 2018-05-10
Route INTRAMUSCULAR, INTRAVENOUS
Dosage form INJECTION, SOLUTION
Substance SUCCINYLCHOLINE CHLORIDE
TE code (Orange Book) AP · RLD · RS
Quick answers
  • RxCUI (RxNorm): 1594589
Why two NDCs? The FDA registers this code as 70771-1352-7 — a 5-4-1 layout, and that's what's printed on the package and shown on DailyMed. For insurance claims, every NDC is standardized to a uniform 11-digit 5-4-2 format by adding a zero to the package segment → 70771-1352-07. Same drug, same package — only the format differs.
Where does this data come from?
Identifiers from the FDA openFDA NDC Directory and Structured Product Labeling; RxCUI from RxNorm (NLM); GPI from Medi-Span; GCN / HIC / AHFS / legend from First Databank.

RxNorm drug class

This medicine belongs to the Depolarizing Neuromuscular Blocker class.

Pharmacologic class Depolarizing Neuromuscular Blocker
Drug family (ATC) Choline derivatives
Where does this data come from?
Therapeutic classes from RxNorm RxClass (U.S. National Library of Medicine) — Established Pharmacologic Class (FDA), ATC drug family (WHO) and mechanism of action, matched by this product’s RxCUI.

Clinical

📗 Our plain-language guide HelloPharmacist
  • It's a fast-acting muscle relaxer used with general anesthesia. It helps your team place a breathing tube and keeps your muscles relaxed during surgery or while you're on a ventila...
  • It's given by injection into a vein or muscle by trained clinicians, so you won't manage it yourself. It works within about a minute by vein and lasts only minutes after a single d...
  • How is it given, and will I feel it working?
  • Muscle soreness, jaw stiffness, extra saliva and temporary changes in heart rate or blood pressure can happen. Brief twitching occurs right as it starts. Your team watches you clos...
📖 Read our full Succinylcholine guide →
Where does this data come from?
Plain-language summary from MedlinePlus (U.S. National Library of Medicine); supplement & herbal interactions and nutrient depletion data from the Natural Medicines database; our full guide is HelloPharmacist editorial content.

Pricing

A drug doesn't have one price. Each row is a different public payment system, and none is what you'd pay at the counter — that depends on your insurance. The ⓘ on each row explains what it measures.

Price systemPer mLPer package
Retail pharmacies payNADAC · weekly Not in the retail survey — common for institutional, discontinued, or low-volume packs.
Medicaid paysCMS SDUD · 12 mo No recent Medicaid claims on file for this NDC — rare and low-volume NDCs are suppressed in the public data.
Medicare drug plans payPart D · quarterly No Part D plan price is available for this NDC in our data.
ℹ️
No price is published for this exact package yet. CMS surveys NADAC per package size, so a different pack of the same drug often has one.
Where does this data come from?
NADAC (National Average Drug Acquisition Cost) is the CMS weekly pharmacy-acquisition-cost survey — what pharmacies pay. ASP (Average Sales Price) is the CMS Medicare Part B drug-payment file, published quarterly. Medicaid pays is computed by us from CMS State Drug Utilization Data (total reimbursed ÷ units, trailing 12 months) — gross of rebates and inclusive of dispensing fees, so it reflects what Medicaid paid, not an acquisition cost. Medicare drug plans pay is the median negotiated point-of-sale unit cost across plans listing this NDC in the CMS quarterly Prescription Drug Plan pricing files, before rebates. The VA pays is the federal contract price (FSS, and the statutory Big 4 ceiling where listed) from the VA National Acquisition Center pharmaceutical price file. All are free public government data; each measures a different payer, so the figures are not directly comparable.

Packaging — all sizes for this product

Package NDCDescription Marketing startMarketing endStatus
70771-1352-07 You're viewing this Main listing 25 VIAL, MULTI-DOSE in 1 TRAY / 10 mL in 1 VIAL, MULTI-DOSE 2018-05-10 — Active

Therapeutic equivalents

ProductLabelerPackNADAC/unitTEStatusPrice vs. this
Succinylcholine Chloride 20 mg/mL 00143-9338-25 Hikma 25 vials — AP FDA listed —
Succinylcholine Chloride 20 mg/mL 00404-9983-20 Henry 1 vial — AP FDA listed —
Quelicin 20 mg/mL 00409-6629-02 Hospira, 25 vials — AP FDA listed —
Anectine 20 mg/mL 00781-3411-95 Sandoz 10 vials — AP FDA listed —
Anectine 20 mg/mL 00781-9053-95 Sandoz 10 vials — AP FDA listed —
Succinylcholine Chloride 20 mg/mL 14445-0407-25 Indoco 25 vials — AP FDA listed —
Succinylcholine Chloride 20 mg/mL 31722-0981-31 Camber 25 vials — AP FDA listed —
Succinylcholine Chloride 200 mg/10mL 42571-0371-87 Micro 25 vials — AP FDA listed —
Succinylcholine 20 mg/mL 43598-0666-25 Dr.Reddy's 25 vials — AP FDA listed —
Succinylcholine Chloride 20 mg/mL 51662-1525-01 HF 10 ml — AP FDA listed —
Succinylcholine Chloride 20 mg/mL 55150-0315-25 Eugia 25 vials — — FDA listed —
Succinylcholine Chloride 20 mg/mL 63323-0943-10 Fresenius 25 vials — AP FDA listed —
Succinylcholine Chloride 20 mg/mL 66794-0232-42 Piramal 25 vials — AP FDA listed —
Succinylcholine Chloride 20 mg/mL 68083-0450-25 Gland 25 vials — AP FDA listed —
Succinylcholine Chloride 20 mg/mL 69918-0700-11 Nordic 10 vials — AP Discontinued —
Succinylcholine Chloride 20 mg/mL 70069-0301-25 Somerset 25 vials — AP FDA listed —
Succinylcholine Chloride 20 mg/mL 70069-0783-10 Somerset 10 vials — AP FDA listed —
Succinylcholine Chloride 20 mg/mL 70121-1581-05 Amneal 25 vials — — Discontinued —
Succinylcholine Chloride 20 mg/mL 70518-4409-00 REMEDYREPACK 10 vials — AP FDA listed —
Succinylcholine Chloride 20 mg/mL 70710-1377-02 Zydus 25 vials — AP FDA listed —
Succinylcholine Chloride 20 mg/mL 70756-0613-10 Lifestar 10 vials — — FDA listed —
Succinylcholine Chloride 20 mg/mLthis 70771-1352-07 Zydus 25 vials — AP FDA listed —
Succinylcholine Chloride 20 mg/mL 71288-0719-11 Meitheal 25 vials — AP FDA listed —
Succinylcholine Chloride 20 mg/mL 71839-0121-25 BE 25 vials — AP FDA listed —
Succinylcholine Chloride 20 mg/mL 71872-7166-01 Medical 1 vial — — FDA listed —
Succinylcholine Chloride 20 mg/mL 71872-7167-01 Medical 1 vial — AP FDA listed —
Succinylcholine Chloride 20 mg/mL 71872-7221-01 Medical 1 vial — AP FDA listed —
Succinylcholine 20 mg/mL 71872-7241-01 Medical 1 vial — AP FDA listed —
Succinylcholine Chloride 20 mg/mL 71872-7272-01 Medical 1 vial — AP FDA listed —
Succinylcholine Chloride 20 mg/mL 71872-7275-01 Medical 1 vial — AP FDA listed —
Succinylcholine Chloride 20 mg/mL 71872-7279-01 Medical 1 vial — AP FDA listed —
Anectine 20 mg/mL 72572-0750-10 Civica, 10 vials — AP FDA listed —
Succinylcholine Chloride 20 mg/mL 73043-0021-01 Devatis, 25 vials — AP FDA listed —
Succinylcholine Chloride 20 mg/mL 84549-0301-25 ProPharma 10 ml — AP FDA listed —
Succinylcholine Chloride 20 mg/mL 82449-0232-02 STERISCIENCE 10 syringes — AP FDA listed —
About this product: this is a generic version of the medicine. FDA equivalence ratings are shown when available, and other versions are listed above, least expensive first.
Where does this data come from?
Equivalents are other NDCs of the same ingredient, form and route from the openFDA NDC Directory, ranked least-expensive-first by NADAC. Therapeutic-equivalence (AB) ratings come from the FDA Orange Book; biologics use the FDA Purple Book for biosimilar & interchangeable status.

Availability & generic status

🏛️
2018
On the market since
May 2018
📍
2026
Currently FDA-listed
8 years listed
🔓
·
Generic on the market
this product is a generic
✅This is a generic drug

This product is an FDA-approved generic. Other versions of the same drug are listed under Therapeutic equivalents, least expensive first.

Where does this data come from?
Patents and exclusivity from the FDA Orange Book (small-molecule drugs), refreshed from public FDA data. Generic launch timing is an estimate, not a guarantee.

Inactive Ingredients / Excipients

Inactive ingredients, also called excipients, are components of the drug product other than the active ingredient. They may include fillers, dyes, coatings, preservatives, flavors, or other formulation ingredients.

💡 Tap an ingredient (hover on desktop) to see what it is and why it’s used.

  • UNII QTT17582CB
    A strong acid used to adjust and maintain the proper pH level in liquid medicines, ensuring stability and preventing breakdown of active ingredients.
  • 1.8 mg / 1 mL UNII A2I8C7HI9T
    Methylparaben is a preservative derived from benzoic acid that prevents growth of bacteria, fungi, and mold in medicines. It extends the product's shelf life and maintains safety during storage.
  • 0.2 mg / 1 mL UNII Z8IX2SC1OH
    Propylparaben is a chemical preservative used to prevent bacterial and fungal growth in medicines and personal care products. It helps extend shelf life and maintain product safety during storage.
  • UNII 451W47IQ8X
    Sodium chloride is common table salt. It's used in medicines as a buffer to maintain proper pH, as a filler to add bulk, or to adjust the osmotic balance in liquid formulations.
  • UNII 55X04QC32I
    A strong alkaline chemical used to adjust and maintain the pH balance of liquid medicines. It helps keep the medicine stable and ensures it stays effective during storage.

5 inactive ingredients listed in the exact product block matched to this NDC.

Where does this data come from?
Data sourced from official FDA Structured Product Labeling (SPL) via DailyMed — ingredient classCode="IACT" elements from the exact product block matched by this NDC. Label-section narrative from DailyMed / the openFDA label index is shown separately when available.

Inactive ingredient FAQ

Are inactive ingredients the same for every manufacturer?
No. Inactive ingredients can differ by manufacturer, dosage form, strength, and package / product version.
Why might an inactive ingredient be missing?
Some SPLs do not provide a complete structured inactive-ingredient list, and older or unusual labels may only include the information in narrative text.
Can inactive ingredients matter?
Yes. They can matter for allergies, intolerances, dyes, gluten / lactose concerns, preservatives, and formulation differences — but confirm with a pharmacist or the manufacturer when it’s clinically important.

Manufacturer & labeler

LabelerZydus Lifesciences Limited
Application holderZYDUS PHARMACEUTICALS USA INC
FDA applicationANDA209467 (ANDA)
Labeler code70771
First marketedMay 2018
Product typeHuman Prescription Drug
Portfolio720 products on file
The labeler markets the product; the application holder owns the FDA approval. They’re often the same company but can differ (e.g. a repackager or an authorized generic). A mailing address / phone appears here when the manufacturer includes it in the product’s FDA label (not all do).
Where does this data come from?
Labeler, application holder and registered establishment from the FDA openFDA NDC Directory and Drugs@FDA; address/contact from the product’s FDA label.

Full prescribing information FDA SPL

The complete FDA label for this product — the official prescribing information, verbatim, section by section. Jump with a chip, search within the label, or expand everything.
📄 Package Label / Principal Display Panel 75 words ▾

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL Vial Label NDC 70771-1352-1 Succinylcholine Chloride Injection, USP 200 mg/10 mL (20 mg/mL) For Intravenous or Intramuscular use. 10 mL Multiple-dose Vial Rx only Zydus Pharmaceuticals container-label

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL Carton Label NDC 70771-1352-7 Succinylcholine Chloride Injection, USP 200 mg/10 mL (20 mg/mL) For Intravenous or Intramuscular use. Store in refrigerator 2º to 8ºC (36º to 46ºF). 25 (25 x 1) 10 mL Multiple-dose Vial Rx only Zydus Pharmaceuticals carton-label

Source: FDA Structured Product Labeling, mirrored from DailyMed / openFDA. Prefer the government’s original formatting? View this label on DailyMed ↗

Reported adverse events (FAERS)

Read carefully: FAERS reports are voluntary and unverified. Counts are not incidence, do not establish causation, are subject to reporting bias, and cannot be used to compare one drug to another. Shown for signal context only. Reports for SUCCINYLCHOLINE CHLORIDE — the ingredient across all brands.

Top reported reactions

Hypotension181
Cardiac Arrest168
Anaphylactic Shock144
Drug Interaction127
Renal Failure120
Pain116
Anaphylactic Reaction112

Age at onset

Neonate31
Infant4
Child15
Adolescent2
Adult184
Elderly51

Reporter sex

2,223 reports

Serious outcomes

Death259
Reports over time (by year) — tap or hover for the count & year
2019 2021 2023 2026 164 60
Most recent year is provisional (FAERS lags ~3 months).
Where does this data come from?
Adverse-event reports from the FDA Adverse Event Reporting System (FAERS) via openFDA. FAERS reports are voluntary and unverified — counts are not incidence and don’t establish causation.

About this NDC listing & data coverage

Finished prescription product
What data is (and isn’t) available for this NDC — tap to expand
NDC identity (package / product / labeler codes) ✓ Available
Labeler ✓ Available
Product & package description ✓ Available
Marketing category & status ✓ Available
Active ingredient / dosage form / route ✓ Available
FDA label (SPL via DailyMed) ✓ Available
Package photos — Not published for this NDC No photo available yet for this listing.
Inactive ingredients (structured) ✓ Available
NADAC pharmacy acquisition price (CMS) — Not published for this NDC CMS publishes NADAC only for NDCs reported in its retail-pharmacy survey.
Orange Book / therapeutic-equivalence data ✓ Available
HCPCS J-code billing crosswalk — Not published for this NDC Most self-administered / retail products have no J-code — that is normal.
Medicaid utilization (CMS SDUD) — Not published for this NDC CMS reports utilization only for NDCs with Medicaid claims above its privacy threshold.
“Not published” reflects what the public FDA / CMS / NLM sources provide for this exact package code — it is a property of the data feeds, not a judgment about the product.

Questions about this listing

Why is there no price listed?
The pricing shown on our NDC pages comes from CMS NADAC, a voluntary survey of retail community pharmacy invoices. CMS does not publish a NADAC for every NDC — packages outside the retail survey (institutional and hospital products, bulk packages, discontinued items, and many OTC items) may never receive one. A missing price reflects the survey's scope, not this product's actual cost, and does not mean the product is free or unavailable.
Is the NDC printed on the package the same as the 11-digit billing NDC?
Yes, they identify this exact package in different formats. The form printed on the packaging and shown on DailyMed is the one the FDA registered. Insurance claims use a fixed 11-digit 5-4-2 format, so the short segment is padded with a leading zero and the dashes are dropped. The Identity section at the top of this page lists each form of this code.
Is this package still being marketed?
Yes, per the latest FDA NDC Directory data on this page: this package is listed as actively marketed, with no marketing end date reported by Zydus Lifesciences Limited. Listing status can change — the directory data on this page refreshes weekly.
Who lists this product with the FDA?
Zydus Lifesciences Limited is the labeler of record for this NDC — the company under whose FDA-assigned code the package is listed. The labeler may be the manufacturer itself or a distributor marketing the product under its own code.
Do I need a prescription for this product?
This NDC is listed with FDA as a prescription product, so it is dispensed under a prescriber's order. Your pharmacist can tell you whether any over-the-counter forms of the same medication exist.
This page identifies an FDA-listed package (the NDC) and reports public regulatory and pricing data about the listing. It is reference information, not a medical recommendation — talk to your pharmacist or prescriber about your own medication.
Where does this data come from?
Listing facts (marketing category, packager status, marketing dates) from the FDA openFDA NDC Directory; label availability from DailyMed; pricing coverage from CMS NADAC; equivalence scope from the FDA Orange Book.
For educational and professional reference only — not medical advice. Pricing reflects published NADAC and CMS ASP (free public data) and may differ from your acquisition cost; always verify before billing or dispensing.